A Procedure That Changed the Game
When Tommy John took the field for the Dubuque Packers in 1961, he was an 18‑year‑old right‑hander with a modest fastball and a hunger to prove himself. After stints with several minor‑league affiliates, he debuted in the majors with the Cleveland Indians and eventually became a mainstay in the National League, pitching for the Los Angeles Dodgers, New York Yankees and California Angels over a 26‑year career.
The turning point arrived in 1974, when John felt a sharp pain in his left elbow while throwing a curveball. An MRI revealed a complete tear of the ulnar collateral ligament — a injury that, at the time, was considered career‑ending. Dr. Frank Jobe, then a young orthopedic surgeon, proposed an experimental technique: harvest a tendon from John’s forearm and graft it into the damaged ligament, a procedure that would later be known as Tommy John surgery.
The operation, performed in September 1974, was followed by a second surgery to reroute a nerve that had been causing chronic pain. Against the odds — Dr. Jobe had initially estimated a 1% chance of recovery — John began a painstaking rehabilitation. He returned to the mound in 1975, and by 1976 he was not only back in the rotation but also posting a 31‑win season for the Los Angeles Dodgers.
John’s resurgence was more than a personal triumph; it heralded a new era for pitchers. He logged three 20‑win seasons between 1977 and 1980, earned four All‑Star selections, and finished his career with a 62.1 bWAR, a 111 ERA+ and 12 shutouts. By 2024, the surgery he helped pioneer had been performed on roughly 36% of all MLB pitchers, including multiple operations on relievers such as Hung‑Chih Kuo and Tejay Antone.
The procedure’s reach extended far beyond professional baseball. Studies showed that by 2014, 67% of all ulnar collateral ligament reconstructions were performed on athletes aged 16 to 20, underscoring its prevalence among young pitchers who increasingly specialize in the sport year‑round. In response, John became an outspoken advocate for cross‑training, urging young athletes to play multiple sports and avoid the wear and tear of a single‑sport schedule.
The personal tragedy of 2010 — when his son Taylor died by suicide — propelled John into the realm of mental‑health advocacy. He partnered with the American Foundation for Suicide Prevention, using his platform to raise awareness and funds for suicide‑prevention programs, thereby weaving a broader narrative of resilience that intertwined physical and emotional well‑being.
John’s influence can be measured not only in statistics but also in the careers of future Hall‑of‑Fame pitchers. Figures such as Jamie Moyer, Julio Franco, Nolan Ryan and Randy Johnson all extended their prime well into their 40s, citing John’s longevity as a model. His Let’s Do It Foundation continued to educate players and coaches about elbow health, cementing his legacy as both a pioneer of medical innovation and a champion of holistic athlete development.